Health Content Overview
eISSN : 0000-0000
10.5
citescore
CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2018-2021) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of these documents in these same four years
10.5
impact factor
CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2018-2021) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of these documents in these same four years (e.g. 2018 – 21).
10.5
pubmed
CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2018-2021) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of these documents in these same four years (e.g. 2018 – 21).
10.5
Embase
Biosis Preview
Volume 11, Issue 5 (2023)
Geo Res 2023, 11(5): 695-700 |
Back to browse issues page
History
Received: 2023/12/12 | Accepted: 2024/04/8 | Published: 2023/05/28
Received: 2023/12/12 | Accepted: 2024/04/8 | Published: 2023/05/28
How to cite this article
Depression’s Associated Factors in Cancer Patients in Post-COVID-19 Pandemic. Geo Res 2023; 11 (5) :695-700
URL: http://daneshafarand.org/article-4-72903-en.html
URL: http://daneshafarand.org/article-4-72903-en.html
Authors
Abstract (1346 Views)
Aims: Quarantine during the COVID-19 pandemic was an important factor in developing depression in cancer patients. Early diagnosing of depression in these patients is a health priority for the medical staff. This study aimed to investigate depression in oncology department patients at the end of the COVID-19 pandemic.
Instrument & Methods: In the present cross-sectional study, the research population included all patients admitted to the oncology department of Shahid Beheshti Hospital and Imam Khomeini Clinic, selected by the convenience sampling method in 2022. Data were collected using a demographic questionnaire and a depression questionnaire. All the analyses of this research were done using SPSS 25 software.
Findings: The Mean depression score was 23.84±9.24. Based on the cutoff points of 13 (mild), 19 (moderate), and 28 (severe) for a total score of depression, 48 patients (16.49%) suffered from mild depression (95%CI: 12.22-20.75), 114 patients (39.17%) suffered from moderate depression (95%CI: 33.56-44.77), and 89 (30.89%) suffered from severe depression (95%CI: 25.29-35.88). The Pearson correlation coefficient also showed significant positive linear correlations between depression and age (r=0.21; p<0.001), age at onset of disease (r=0.20; p=0.001), length of disease (r=0.24; p<0.001) and length of chemotherapy (r=0.14; p=0.016).
Conclusion: Most cancer patients suffer from moderate to severe depression. Since there is a relationship between depression, the duration of the disease, and the duration of chemotherapy, it is recommended to check these patients for depression periodically.
Instrument & Methods: In the present cross-sectional study, the research population included all patients admitted to the oncology department of Shahid Beheshti Hospital and Imam Khomeini Clinic, selected by the convenience sampling method in 2022. Data were collected using a demographic questionnaire and a depression questionnaire. All the analyses of this research were done using SPSS 25 software.
Findings: The Mean depression score was 23.84±9.24. Based on the cutoff points of 13 (mild), 19 (moderate), and 28 (severe) for a total score of depression, 48 patients (16.49%) suffered from mild depression (95%CI: 12.22-20.75), 114 patients (39.17%) suffered from moderate depression (95%CI: 33.56-44.77), and 89 (30.89%) suffered from severe depression (95%CI: 25.29-35.88). The Pearson correlation coefficient also showed significant positive linear correlations between depression and age (r=0.21; p<0.001), age at onset of disease (r=0.20; p=0.001), length of disease (r=0.24; p<0.001) and length of chemotherapy (r=0.14; p=0.016).
Conclusion: Most cancer patients suffer from moderate to severe depression. Since there is a relationship between depression, the duration of the disease, and the duration of chemotherapy, it is recommended to check these patients for depression periodically.
Keywords:
| | Full-Text (HTML) (219 Views)